EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Benchmarking enrichment analysis methods with the disease pathway network

Davide Buzzao iD, Miguel Castresana-Aguirre, Dimitri Guala iD, Erik L L Sonnhammer

Briefings in Bioinformatics · 22.01.2024 · 25 (2)

DOI: 10.1093/bib/bbae069 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Briefings in Bioinformatics, online erschienen am 02.03.2024. Verfasst von Davide Buzzao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Biophysics, Stockholm University, Science for Life Laboratory, Box 1031, 171 21 Solna, Sweden. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Research Council, Stockholm University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Enrichment analysis (EA) is a common approach to gain functional insights from genome-scale experiments. As a consequence, a large number of EA methods have been developed, yet it is unclear from previous studies which method is the best for a given dataset. The main issues with previous benchmarks include the complexity of correctly assigning true pathways to a test dataset, and lack of generality of the evaluation metrics, for which the rank of a single target pathway is commonly used. We here provide a generalized EA benchmark and apply it to the most widely used EA methods, representing all four categories of current approaches. The benchmark employs a new set of 82 curated gene expression datasets from DNA microarray and RNA-Seq experiments for 26 diseases, of which only 13 are cancers. In order to address the shortcomings of the single target pathway approach and to enhance the sensitivity evaluation, we present the Disease Pathway Network, in which related Kyoto Encyclopedia of Genes and Genomes pathways are linked. We introduce a novel approach to evaluate pathway EA by combining sensitivity and specificity to provide a balanced evaluation of EA methods. This approach identifies Network Enrichment Analysis methods as the overall top performers compared with overlap-based methods. By using randomized gene expression datasets, we explore the null hypothesis bias of each method, revealing that most of them produce skewed P-values.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA-Seq

Stichwörter der Autor:innen

disease pathway networkfunctional enrichmentgene expression datagene set enrichment analysispathway enrichment analysissystems biology

Autor:innen und Institutionen

  • Department of Biochemistry and Biophysics, Stockholm University, Science for Life Laboratory, Box 1031, 171 21 Solna, Sweden.
  • K7 Department of Oncology-Pathology, Karolinska Institute, 171 77 Stockholm, Sweden.

ORCID-Profile: Davide Buzzao, Dimitri Guala

Förderung

  • Swedish Research Council
  • Stockholm University

Zitieren

APA

Buzzao, D., Castresana-Aguirre, M., Guala, D., & Sonnhammer, E. L. L. (2024). Benchmarking enrichment analysis methods with the disease pathway network. Briefings in Bioinformatics, 25(2). https://doi.org/10.1093/bib/bbae069

Vancouver

Buzzao D, Castresana-Aguirre M, Guala D, Sonnhammer ELL. Benchmarking enrichment analysis methods with the disease pathway network. Briefings in Bioinformatics. 2024;25(2). doi:10.1093/bib/bbae069

BibTeX
@article{Buzzao2024,
  author = {Buzzao, Davide and Castresana-Aguirre, Miguel and Guala, Dimitri and Sonnhammer, Erik L L},
  title = {Benchmarking enrichment analysis methods with the disease pathway network},
  journal = {Briefings in Bioinformatics},
  year = {2024},
  volume = {25},
  number = {2},
  doi = {10.1093/bib/bbae069}
}
Kostenlos starten →